BOSTON and TAMPA, Fla. – PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospitals and a leader in cancer research, today announced a multi-year...

Boston, MA – August 26, 2025 – PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the expansion of the AISight® Dx digital pathology image management system 510(k) label (K243391)...

Boston - June 30, 2025  -  PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight®...

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6,...

Precision for Medicine and PathAI: Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery BOSTON and FREDERICK, Md., April 25,...

PathAI to present key research advancing digital pathology and host a networking event, H&E by the Sea, on March 25th at 6:00 p.m. ET at Nautilus Pier 4 BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered...